| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.28B | 14.19B | 9.87B | 10.87B | 7.99B | 8.95B |
| Gross Profit | 2.99B | 5.15B | 3.84B | 4.08B | 2.85B | 2.87B |
| EBITDA | 307.17M | 2.03B | 1.09B | 1.66B | 617.63M | 730.58M |
| Net Income | 224.97M | 1.64B | 728.30M | 2.29B | 271.19M | 414.58M |
Balance Sheet | ||||||
| Total Assets | 21.17B | 21.11B | 21.17B | 20.90B | 17.64B | 15.63B |
| Cash, Cash Equivalents and Short-Term Investments | 11.43B | 12.31B | 12.01B | 12.00B | 8.21B | 7.85B |
| Total Debt | 48.56M | 42.13M | 108.19M | 317.49M | 274.66M | 297.66M |
| Total Liabilities | 5.79B | 3.83B | 5.06B | 4.75B | 2.63B | 2.21B |
| Stockholders Equity | 15.38B | 17.27B | 16.11B | 16.15B | 15.01B | 13.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.14B | 771.97M | 2.37B | 538.34M | 1.64B |
| Operating Cash Flow | 0.00 | 1.86B | 878.18M | 2.53B | 589.82M | 1.74B |
| Investing Cash Flow | 0.00 | -806.66M | -9.82M | 1.41B | -63.30M | -47.03M |
| Financing Cash Flow | 0.00 | -762.46M | -852.92M | -158.29M | -166.47M | -271.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥17.79B | 10.87 | ― | 3.42% | 43.76% | 124.74% | |
66 Neutral | ¥165.08B | 9.48 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥71.43B | 8.76 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥28.11B | 9.22 | ― | 2.40% | 13.67% | 77.59% | |
57 Neutral | ¥63.44B | 12.92 | ― | 2.73% | -1.96% | 26.37% | |
54 Neutral | ¥2.73B | -1.75 | ― | 4.68% | 1.19% | -2435.84% |